Try it
Pharmacology · Antiepileptics: carbamazepine in trigeminal neuralgia
Sample itemA 60-year-old woman with lancinating facial pain triggered by touching her cheek is diagnosed with trigeminal neuralgia. Which is the drug of choice, and which adverse effect should be monitored?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
D. Carbamazepine, with monitoring for hyponatraemia and blood counts
Carbamazepine blocks voltage-gated sodium channels and is the first-line drug in trigeminal neuralgia. Adverse effects include hyponatraemia from enhanced ADH action, aplastic anaemia, hepatotoxicity and skin reactions.
Option by option
A. Phenytoin, with monitoring for goitre
Phenytoin is a second option and does not cause goitre.
B. Ethosuximide, with monitoring for rash
Ethosuximide is for absence seizures.
C. Valproate, with monitoring for neutropenia only
Valproate is not first line for trigeminal neuralgia.
D. Carbamazepine, with monitoring for hyponatraemia and blood counts (correct)
Correct. Carbamazepine, watch sodium and counts.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Pharmacology questions
- Emergency drugsA patient develops stridor, wheeze and hypotension minutes after an injection. What is t…
- AntiepilepticsWhat is the preferred first-line drug for a patient in generalised convulsive status epi…
- AntimicrobialsWhich drug can cause a disulfiram-like reaction when taken with alcohol?
- AntiepilepticsWhich drug is preferred for uncomplicated childhood absence seizures?